Advances in Cancer Treatment (Record no. 9854)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03692nam a22002897a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192638.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 230117b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783030683344 |
| International Standard Book Number | 3030683346 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.994 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Iago Dillion Lima Cavalcanti |
| 9 (RLIN) | 48239 |
| 222 ## - KEY TITLE | |
| Key title | Common terms and phrases |
| Qualifying information | acid activity acute addition allow anticancer antigen antineoplastic agents applications associated binding Biol biological bladder breast cancer cancer cells cancer therapy cancer treatment carcinoma cardiotoxicity cause cell cycle cell lung cancer cellular changes chemotherapy Clin clinical colorectal cancer combined damage delivery diagnosis disease drugs effects et al function gene growth factor human ifosfamide imatinib immune system immunotherapy increase Indication induce inhibitors inhibits leukemia levels liposomes liver lymphoma malignant mechanisms mechanisms of action metastatic molecular monoclonal antibodies mutations nanoparticles nanosystems normal Oncol oncology organs ovarian patients phase present produced prostate cancer protein receptor Reference resistance response role shows signaling solid Source specific staging synthesis Table targeted therapy Ther therapeutic tion tissue toxicity treat treatment of cancer tumor tumor cells tumor markers types vaccines vincristine Wang |
| 245 ## - TITLE STATEMENT | |
| Title | Advances in Cancer Treatment |
| Remainder of title | From Systemic Chemotherapy to Targeted Therapy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Universidade Federal de Pernambuco Recife Pernambuco Brazil: |
| Name of publisher, distributor, etc. | Springer Nature, |
| Date of publication, distribution, etc. | c2021 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 109 pages |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment.<br/><br/>We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells.<br/><br/>The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment.<br/><br/>This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Pharmacy |
| 9 (RLIN) | 27229 |
| General subdivision | Medical / Oncology / General |
| 9 (RLIN) | 26891 |
| General subdivision | Medical / Internal Medicine |
| 9 (RLIN) | 26949 |
| General subdivision | Medical / Clinical Medicine |
| 9 (RLIN) | 26816 |
| General subdivision | Medical › Oncology › General |
| 9 (RLIN) | 47458 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 48240 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | E-BOOKS |
| Source of classification or shelving scheme | ddc |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 01/17/2023 | 616.994 | EBS13904 | 01/17/2023 | EBS13904 | 01/17/2023 | E-BOOKS |